Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Biologics

Biological Therapeutics to be an Important Focus at the 5th Modern Drug Discovery & Development Summit held by GTCbio

Research in biologics has become a hot area for many large pharmaceutical companies as expiring patents, a flood of generic drugs, and slowing growth in small-molecule drug pipelines have led to decreasing revenues. Many "big pharma" companies have begun to invest aggressively in new biologics programs, biotech acquisitions, and facilities construction in pursuit of new avenues for robust revenue growth. Growing interest in biologics also affords a risk management strategy -- providing greater diversity for...

• View Other Issues of Vaccine Weekly
  
• View Other NewsRx Publications